THE NICKLES GROUP, LLC for CSL BEHRING LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Budget/Appropriations BUD
Monitored H.R. 4378, the Continuing Appropriations Act of 2020 and Health Extenders Act of 2019.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.